| Health Canada | backgrounders
The Government of Canada is releasing new data from the national biomonitoring program with results from the Canadian Health Measures Survey (CHMS).
| Health Canada | news releases
This week, Health Canada and Statistics Canada released new results from the biomonitoring component of the Canadian Health Measures Survey (CHMS). The biomonitoring component of the CHMS collects meaningful data that informs evidence-based decisions to protect the health and safety of Canadians.
| Health Canada | news releases
Today, the Honourable Patty Hajdu, Minister of Health, and the Honourable Joyce Murray, Minister of Digital Government, announced that COVID Alert has been updated with two new features.
| Health Canada | media advisories
On December 9, 2020, Health Canada authorized the Pfizer-BioNTech COVID-19 vaccine.
| Health Canada | statements
On December 9, 2020, Health Canada authorized the Pfizer-BioNTech COVID-19 vaccine.
| Health Canada | statements
Health Canada is aware that the UK Medicines and Healthcare Products Regulatory Agency has issued a temporary authorization for temporary limited supply of its first COVID-19 vaccine, manufactured by Pfizer/BioNTech.
| Health Canada | backgrounders
The Interim Order Respecting Drug Shortages (Safeguarding the Drug Supply) puts in place a framework to provide the Minister of Health with tools to help prevent or alleviate drug shortages, or the risk of drug shortages, that may be caused or exacerbated by the distribution of drugs intended for the Canadian market for consumption outside Canada.
| Health Canada | news releases
Starting November 27, certain drugs intended for the Canadian market are prohibited from being distributed for consumption outside of Canada if that sale would cause or worsen a drug shortage. Companies will now also be required to provide information to assess existing or potential shortages, when requested, and within 24 hours if there is a serious or imminent health risk.
| Health Canada | backgrounders
Nearly $3.5 million in funding for three chronic pain projects is being provided to improve the health outcomes of people who are seeking care to prevent or manage pain, substance use, or a related disability. Funding is provided through the Substance Use and Addictions Program (SUAP), which supports evidence-informed and innovative initiatives across a range of interventions—health promotion, prevention, harm reduction and treatment—targeting a broad range of legal and illegal substances.
| Health Canada | news releases
Today, as Canada marks National Pain Awareness Week, the Honourable Patty Hajdu, Minister of Health, announced the release of the Canadian Pain Task Force’s second report. The Minister also confirmed nearly $3.5 million in funding for three projects that will help provide support and access to care for people living with chronic pain.
